{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:21:25Z","timestamp":1768011685292,"version":"3.49.0"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute on Aging","award":["R21AG046711"],"award-info":[{"award-number":["R21AG046711"]}]},{"name":"National Institute on Aging","award":["R21AG055113"],"award-info":[{"award-number":["R21AG055113"]}]},{"name":"National Institute on Aging","award":["P50AG047266"],"award-info":[{"award-number":["P50AG047266"]}]},{"name":"National Institute on Aging","award":["8AZ20"],"award-info":[{"award-number":["8AZ20"]}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health Ed and Ethel Moore Alzheimer\u2019s Disease Research program","doi-asserted-by":"publisher","award":["R21AG046711"],"award-info":[{"award-number":["R21AG046711"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health Ed and Ethel Moore Alzheimer\u2019s Disease Research program","doi-asserted-by":"publisher","award":["R21AG055113"],"award-info":[{"award-number":["R21AG055113"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health Ed and Ethel Moore Alzheimer\u2019s Disease Research program","doi-asserted-by":"publisher","award":["P50AG047266"],"award-info":[{"award-number":["P50AG047266"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health Ed and Ethel Moore Alzheimer\u2019s Disease Research program","doi-asserted-by":"publisher","award":["8AZ20"],"award-info":[{"award-number":["8AZ20"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The amyloid pathology characteristic of Alzheimer\u2019s disease (AD) can be broadly classified as either fibrillary amyloid or diffuse amyloid. Fibrillary amyloid is found in cored-neuritic deposits, fibrillar deposits, and vascular deposits, and binds strongly to the amyloid revealing dyes Thioflavin-S or Congo Red. Diffuse amyloid can appear as wispy dispersed deposits or compact tufted deposits dispersed in neuropil, and binds amyloid dyes weakly if at all. In AD brains, both types of pathology are detected. Homogenates from AD brains, or the brains of transgenic mice modeling AD-amyloidosis, have been used to seed pathology in vulnerable host transgenic models. These studies suggest that pathologies may arise from distinct conformers or strains of misfolded A\u03b2, similar to propagating prions. Using A\u03b2 strains sourced from four different AD-amyloidosis models, we injected pathological seeds into the brains of newborn mice from three different transgenic hosts with distinctive A\u03b2 pathologies. Two of the seeding sources were from mice that primarily develop cored-neuritic A\u03b2 deposits (cored strain) while the other two seeding sources were from mice that develop diffuse A\u03b2 deposits (diffuse strain). These seeds were injected into host APP mice in which the resident strain was either diffuse or cored-neuritic pathology. Seeding-homogenates were injected into the brains of newborn mice to initiate propagation as early as possible. Depending upon the level of transgene expression in the host, we show that the injected strains of misfolded A\u03b2 from the seeding homogenate were able to outcompete the resident strain of the APP host model. In serial passaging experiments, it appeared that the diffuse strain was more easily propagated than the cored strain. Collectively, our studies align with the idea that different types of A\u03b2 pathology in AD brains arise from different populations of A\u03b2 conformers that compete to populate the brain.<\/jats:p>","DOI":"10.3390\/biom12070886","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T10:39:13Z","timestamp":1656153553000},"page":"886","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Modeling the Competition between Misfolded A\u03b2 Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"12","author":[{"given":"Guilian","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Fromholt","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-6979","authenticated-orcid":false,"given":"David R.","family":"Borchelt","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s (2021). 2021 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 17, 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: The influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins","volume":"58","author":"Huynh","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1073\/pnas.162228299","article-title":"Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease","volume":"99","author":"DeMattos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 Accelerates Early Seeding of Amyloid Pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apoplipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer\u2019s disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-109-1-41","article-title":"Brain amyloid and Alzheimer disease","volume":"109","author":"Vinters","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(01)00169-5","article-title":"The morphological phenotype of \u03b2-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease","volume":"105","author":"Dickson","year":"2001","journal-title":"Neuroscience"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","article-title":"Neuropathology of cognitively normal elderly","volume":"62","author":"Knopman","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-020-00911-y","article-title":"Diversity in A\u03b2 deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis","volume":"8","author":"Xu","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.abm7285","article-title":"Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains","volume":"375","author":"Yang","year":"2022","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","article-title":"Evidence for seeding of \u03b2-amyloid by intracerebral infusion of Alzheimer brain extracts in \u03b2-amyloid precursor protein-transgenic mice","volume":"20","author":"Kane","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/B978-0-444-63945-5.00016-7","article-title":"Prion-like mechanisms in Alzheimer disease","volume":"153","author":"Walker","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"a023507","DOI":"10.1101\/cshperspect.a023507","article-title":"\u03b2-Amyloid Prions and the Pathobiology of Alzheimer\u2019s Disease","volume":"8","author":"Watts","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-020-02201-2","article-title":"The existence of A\u03b2 strains and their potential for driving phenotypic heterogeneity in Alzheimer\u2019s disease","volume":"142","author":"Lau","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-021-00429-4","article-title":"Remodeling Alzheimer-amyloidosis models by seeding","volume":"16","author":"Ulm","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"a024398","DOI":"10.1101\/cshperspect.a024398","article-title":"The Prion-like Properties of Amyloid-\u03b2 Assemblies: Implications for Alzheimer\u2019s Disease","volume":"6","author":"Walker","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: A comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: Evidence for augmentation of a 42-specific \u03b3 secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40478-015-0252-9","article-title":"Murine A\u03b2 over-production produces diffuse and compact Alzheimer-type amyloid deposits","volume":"3","author":"Xu","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_26","first-page":"9","article-title":"Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse A\u03b2 plaque pathology when injected into newborn mouse hosts","volume":"3","author":"Moore","year":"2022","journal-title":"Free Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","article-title":"A\u03b242 is essential for parenchymal and vascular amyloid deposition in mice","volume":"47","author":"McGowan","year":"2005","journal-title":"Neuron"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.25407","article-title":"Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura","volume":"85","author":"Banerjee","year":"2019","journal-title":"Ann. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-017-0503-z","article-title":"Iatrogenic Creutzfeldt-Jakob disease with Amyloid-\u03b2 pathology: An international study","volume":"6","author":"Cali","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13506129.2020.1854715","article-title":"Cerebral amyloid angiopathy in a 51-year-old patient with embolization by dura mater extract and surgery for nasopharyngeal angiofibroma at age 17","volume":"28","author":"Caroppo","year":"2021","journal-title":"Amyloid"},{"key":"ref_31","first-page":"w14287","article-title":"Amyloid-\u03b2 pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting","volume":"146","author":"Frontzek","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-016-1588-3","article-title":"Significant association of cadaveric dura mater grafting with subpial A\u03b2 deposition and meningeal amyloid angiopathy","volume":"132","author":"Hamaguchi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00401-018-1828-9","article-title":"Fatal A\u03b2 cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years","volume":"135","author":"Cabrejo","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/neup.12503","article-title":"Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-\u03b2 deposition","volume":"38","author":"Iwasaki","year":"2018","journal-title":"Neuropathology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00401-016-1565-x","article-title":"Dura mater is a potential source of A\u03b2 seeds","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jnnp-2019-321927","article-title":"Amyloid-\u03b2 transmission through cardiac surgery using cadaveric dura mater patch","volume":"91","author":"Raposo","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-021-02326-y","article-title":"Alzheimer\u2019s disease neuropathological change three decades after iatrogenic amyloid-\u03b2 transmission","volume":"142","author":"Jaunmuktane","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-017-1791-x","article-title":"Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology","volume":"135","author":"Duyckaerts","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-017-1703-0","article-title":"Amyloid-\u03b2 accumulation in the CNS in human growth hormone recipients in the UK","volume":"134","author":"Ritchie","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1474-4422(20)30238-6","article-title":"Potential human transmission of amyloid \u03b2 pathology: Surveillance and risks","volume":"19","author":"Lauwers","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","article-title":"Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques","volume":"25","author":"Lee","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"\u03b3-Secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of \u03b2-carboxyl terminal fragment","volume":"29","author":"Takami","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41380-019-0410-8","article-title":"Familial Alzheimer\u2019s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta","volume":"25","author":"Arber","year":"2020","journal-title":"Mol. Psychiatry"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/7\/886\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:53Z","timestamp":1760139593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/7\/886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["biom12070886"],"URL":"https:\/\/doi.org\/10.3390\/biom12070886","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]}}}